34956307|t|Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer's Disease.
34956307|a|Previously, we demonstrated an integrated genomic convergence and network analysis approach to identify the candidate genes associated with the complex neurodegenerative disorder, Alzheimer's disease (AD). Here, we performed a pilot study to validate the in silico approach by studying the association of genetic variants from three identified critical genes, APOE, EGFR, and ACTB, with AD. A total of 103 patients with AD and 146 healthy controls were recruited. A total of 46 single-nucleotide polymorphisms (SNPs) spanning the three genes were genotyped, of which only 19 SNPs were included in the final analyses after excluding non-polymorphic and Hardy-Weinberg equilibrium-violating SNPs. Apart from our previously reported APOE epsilon4, four other SNPs in APOE (rs405509, rs7259620, -rs769449, and rs7256173), one in EGFR (rs6970262), and one in ACTB (rs852423) showed a significant association with AD (p < 0.05). Our results validate the reliability of genomic convergence and network analysis approach in identifying the AD-associated candidate genes.
34956307	123	142	Alzheimer's Disease	Disease	MESH:D000544
34956307	296	322	neurodegenerative disorder	Disease	MESH:D019636
34956307	324	343	Alzheimer's disease	Disease	MESH:D000544
34956307	345	347	AD	Disease	MESH:D000544
34956307	504	508	APOE	Gene	348
34956307	510	514	EGFR	Gene	1956
34956307	520	524	ACTB	Gene	60
34956307	531	533	AD	Disease	MESH:D000544
34956307	550	558	patients	Species	9606
34956307	564	566	AD	Disease	MESH:D000544
34956307	908	912	APOE	Gene	348
34956307	914	922	rs405509	SNP	tmVar:rs405509;VariantGroup:5;CorrespondingGene:348;RS#:405509;CorrespondingSpecies:9606
34956307	924	933	rs7259620	SNP	tmVar:rs7259620;VariantGroup:2;CorrespondingGene:348;RS#:7259620;CorrespondingSpecies:9606
34956307	936	944	rs769449	SNP	tmVar:rs769449;VariantGroup:4;CorrespondingGene:348;RS#:769449;CorrespondingSpecies:9606
34956307	950	959	rs7256173	SNP	tmVar:rs7256173;VariantGroup:1;CorrespondingGene:348;RS#:7256173;CorrespondingSpecies:9606
34956307	969	973	EGFR	Gene	1956
34956307	975	984	rs6970262	SNP	tmVar:rs6970262;VariantGroup:3;CorrespondingGene:1956;RS#:6970262;CorrespondingSpecies:9606
34956307	998	1002	ACTB	Gene	60
34956307	1004	1012	rs852423	SNP	tmVar:rs852423;VariantGroup:0;CorrespondingGene:60;RS#:852423;CorrespondingSpecies:9606
34956307	1052	1054	AD	Disease	MESH:D000544
34956307	1176	1178	AD	Disease	MESH:D000544
34956307	Positive_Correlation	MESH:D000544	RS#:405509;CorrespondingGene:348
34956307	Association	MESH:D000544	RS#:7256173;CorrespondingGene:348
34956307	Association	MESH:D000544	RS#:769449;CorrespondingGene:348
34956307	Association	MESH:D000544	RS#:852423;CorrespondingGene:60
34956307	Association	MESH:D000544	348
34956307	Association	MESH:D000544	RS#:6970262;CorrespondingGene:1956
34956307	Association	MESH:D000544	60
34956307	Association	MESH:D000544	1956
34956307	Association	MESH:D000544	RS#:7259620;CorrespondingGene:348
34956307	Association	MESH:D000544	348
34956307	Association	MESH:D000544	60
34956307	Association	MESH:D000544	1956

